The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Chitosan Nanoparticles: A Promising System in Novel Drug Delivery
Open accessAbstract
The ability of nanoparticles to manipulate the molecules and their structures has revolutionized the conventional drug delivery system. The chitosan nanoparticles, because of their biodegradability, biocompatibility, better stability, low toxicity, simple and mild preparation methods, offer a valuable tool to novel drug delivery systems in the present scenario. Besides ionotropic gelation method, other methods such as microemulsion method, emulsification solvent diffusion method, polyelectrolyte complex method, emulsification cross-linking method, complex coacervation method and solvent evaporation method are also in use. The chitosan nanoparticles have also been reported to have key applications in parentral drug delivery, per-oral administration of drugs, in non-viral gene delivery, in vaccine delivery, in ocular drug delivery, in electrodeposition, in brain targeting drug delivery, in stability improvement, in mucosal drug delivery in controlled drug delivery of drugs, in tissue engineering and in the effective delivery of insulin. The present review describes origin and properties of chitosan and its nanoparticles along with the different methods of its preparation and the various areas of novel drug delivery where it has got its application.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers
Calvo, P., Remu��n-L�pez, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Journal of Applied Polymer Science · doi:10.1002/(sici)1097-4628(19970103)63:1<125::aid-app13>3.0.co;2-4 · Cited by 1,856
Alginate in Drug Delivery Systems
Tønnesen, H. H., & Karlsen, J. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120003853 · Cited by 1,509
Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency
Mao, H.-Q., Roy, K., Troung-Le, V. L., Janes, K. A., Lin, K. Y., Wang, Y., August, J. T., & Leong, K. W. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00361-8 · Cited by 1,228
Roy, K., Mao, H.-Q., Huang, S. K., & Leong, K. W. (1999) · Nature Medicine · doi:10.1038/7385 · Cited by 1,106
Gan, Q., Wang, T., Cochrane, C., & McCarron, P. (2005) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2005.06.001 · Cited by 908
Cationic Polymer Based Gene Delivery Systems
De Smedt, S. C., Demeester, J., & Hennink, W. E. (2000) · Pharmaceutical Research · doi:10.1023/a:1007548826495 · Cited by 884
Calvo, P., Remuñan-López, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012128907225 · Cited by 817
Chitosan: some pharmaceutical and biological aspects - an update
Singla, A. K., & Chawla, M. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011776441 · Cited by 784
Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
Artursson, P., Lindmark, T., Davis, S. S., & Illum, L. (1994) · Pharmaceutical Research · doi:10.1023/a:1018967116988 · Cited by 765
Chitosan as a novel nasal delivery system for vaccines
Illum, L., Jabbal-Gill, I., Hinchcliffe, M., Fisher, A. N., & Davis, S. S. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00171-5 · Cited by 755
Chitosan nanoparticles as delivery systems for doxorubicin
Janes, K. A., Fresneau, M. P., Marazuela, A., Fabra, A., & Alonso, M. J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00294-2 · Cited by 721
Pan, Y., Li, Y.-J., Zhao, H.-Y., Zheng, J.-M., Xu, H., Wei, G., Hao, J.-S., & Cui, F.-D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00486-6 · Cited by 686
Cell sheet engineering for myocardial tissue reconstruction
Shimizu, T., Yamato, M., Kikuchi, A., & Okano, T. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00110-8 · Cited by 673
Pharmaceutical applications of chitosan
Dodane, V., & Vilivalam, V. D. (1998) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(98)00059-5 · Cited by 663
Development and characterisation of chitosan nanoparticles for siRNA delivery
Katas, H., & Alpar, H. O. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.07.021 · Cited by 642
Microvascular permeability of normal and neoplastic tissues
Gerlowski, L. E., & Jain, R. K. (1986) · Microvascular Research · doi:10.1016/0026-2862(86)90018-x · Cited by 622
Design of biodegradable particles for protein delivery
Vila, A., Sánchez, A., Tobı́o, M., Calvo, P., & Alonso, M. J. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00486-2 · Cited by 620
Alginate/Chitosan Nanoparticles are Effective for Oral Insulin Delivery
Sarmento, B., Ribeiro, A., Veiga, F., Sampaio, P., Neufeld, R., & Ferreira, D. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9367-4 · Cited by 617
Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
Fernández-Urrusuno, R., Calvo, P., Remuñán-López, C., Vila-Jato, J. L., & José Alonso, M. (1999) · Pharmaceutical Research · doi:10.1023/a:1018908705446 · Cited by 587
Effect of chitosan on epithelial permeability and structure
Dodane, V (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00030-7 · Cited by 578
Chitosan-Based Particles as Controlled Drug Delivery Systems
Prabaharan, M., & Mano, J. F. (2004) · Drug Delivery · doi:10.1080/10717540590889781 · Cited by 564
DNA-polycation nanospheres as non-viral gene delivery vehicles
Leong, K. W., Mao, H.-Q., Truong-Le, V. L., Roy, K., Walsh, S. M., & August, J. T. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00252-6 · Cited by 538
Erbacher, P., Zou, S., Bettinger, T., Steffan, A.-M., & Remy, J.-S. (1998) · Pharmaceutical Research · doi:10.1023/a:1011981000671 · Cited by 536
SARMENTO, B., FERREIRA, D., VEIGA, F., & RIBEIRO, A. (2006) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2006.02.008 · Cited by 532
Niwa, T., Takeuchi, H., Hino, T., Kunou, N., & Kawashima, Y. (1993) · Journal of Controlled Release · doi:10.1016/0168-3659(93)90097-o · Cited by 483
Colloidal Drug Delivery Systems
Kreuter, J. (2014) · CRC Press eBooks · doi:10.1201/9781498710565 · Cited by 469
Chitosan and its derivatives in mucosal drug and vaccine delivery
van der Lubben, I. M., Verhoef, J. C., Borchard, G., & Junginger, H. E. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00172-5 · Cited by 456
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice
Vila, A., Sánchez, A., Janes, K., Behrens, I., Kissel, T., Jato, J. L. V., & Alonso, M. J. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2003.09.006 · Cited by 449
Physicochemical characterization of chitosan nanoparticles: electrokinetic and stability behavior
López-León, T., Carvalho, E. L. S., Seijo, B., Ortega-Vinuesa, J. L., & Bastos-González, D. (2005) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2004.08.186 · Cited by 444
Chitosan nanoparticles for oral drug and gene delivery
Bowman, K., & Leong, K. W. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.2.117 · Cited by 439
Development of a New Drug Carrier Made from Alginate
Rajaonarivony, M., Vauthier, C., Couarraze, G., Puisieux, F., & Couvreur, P. (1993) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600820909 · Cited by 429
Blood compatibility and biodegradability of partially N-acylated chitosan derivatives
Lee, K. Y., Ha, W. S., & Park, W. H. (1995) · Biomaterials · doi:10.1016/0142-9612(95)98126-y · Cited by 428
Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A
El-Shabouri, M. H. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00461-1 · Cited by 392
Köping-Höggård, M., Vårum, K., Issa, M., Danielsen, S., Christensen, B., Stokke, B., & Artursson, P. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302312 · Cited by 385
Schipper, N. G. M., Vårum, K. M., & Artursson, P. (1996) · Pharmaceutical Research · doi:10.1023/a:1016444808000 · Cited by 384
The depolymerization of chitosan: effects on physicochemical and biological properties
Mao, S., Shuai, X., Unger, F., Simon, M., Bi, D., & Kissel, T. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.05.019 · Cited by 376
Huang, M., Fong, C.-W., Khor, E., & Lim, L.-Y. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.05.004 · Cited by 374
Ren, D., Yi, H., Wang, W., & Ma, X. (2005) · Carbohydrate Research · doi:10.1016/j.carres.2005.07.022 · Cited by 374
Behrens, I., Pena, A. I. V., Alonso, M. J., & Kissel, T. (2002) · Pharmaceutical Research · doi:10.1023/a:1019854327540 · Cited by 372
Evaluation of the clearance characteristics of bioadhesive systems in humans
Soane, R. J., Frier, M., Perkins, A. C., Jones, N. S., Davis, S. S., & Illum, L. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00367-6 · Cited by 360
Felt, O. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00003-4 · Cited by 358
Chitosan for mucosal vaccination
van der Lubben, I. M., Verhoef, J. C., Borchard, G., & Junginger, H. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00197-1 · Cited by 357
The effect of the degree of chitosan deacetylation on the efficiency of gene transfection
Kiang, T., Wen, J., Lim, H. W., & Leong, K. W. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.12.036 · Cited by 356
The Impact of Nanobiotechnology on the Development of New Drug Delivery Systems
Kayser, O., Lemke, A., & Hernandez-Trejo, N. (2005) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201053167158 · Cited by 349
Preparation and Characterization of Nanoparticles Shelled with Chitosan for Oral Insulin Delivery
Lin, Y.-H., Mi, F.-L., Chen, C.-T., Chang, W.-C., Peng, S.-F., Liang, H.-F., & Sung, H.-W. (2007) · Biomacromolecules · doi:10.1021/bm0607776 · Cited by 349
Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers
Calvo, P., Vila-Jato, J. L., & Alonso, M. J. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00083-5 · Cited by 347
Muzzarelli, R. (1996) · Carbohydrate Polymers · doi:10.1016/s0144-8617(96)00033-1 · Cited by 334
Zhang, H., & Neau, S. H. (2001) · Biomaterials · doi:10.1016/s0142-9612(00)00326-4 · Cited by 330
Dyer, A. M., Hinchcliffe, M., Watts, P., Castile, J., Jabbal-Gill, I., Nankervis, R., Smith, A., & Illum, L. (2002) · Pharmaceutical Research · doi:10.1023/a:1016418523014 · Cited by 280
A Novel Approach to the Oral Delivery of Micro- or Nanoparticles
Bodmeier, R., Chen, H., & Paeratakul, O. (1989) · Pharmaceutical Research · doi:10.1023/a:1015987516796 · Cited by 276
Lueßen, H. L., de Leeuw, B. J., Langemeÿer, M. W. E., de Boer, A. G., Verhoef, J. C., & Junginger, H. E. (1996) · Pharmaceutical Research · doi:10.1023/a:1016488623022 · Cited by 273
van der Merwe, S. M., Verhoef, J. C., Verheijden, J. H. M., Kotzé, A. F., & Junginger, H. E. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.023 · Cited by 260
Sarmento, B., Ribeiro, A. J., Veiga, F., Ferreira, D. C., & Neufeld, R. J. (2007) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2007.609 · Cited by 242
Sadeghi, A. M. M., Dorkoosh, F. A., Avadi, M. R., Saadat, P., Rafiee-Tehrani, M., & Junginger, H. E. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.052 · Cited by 238
Tabata, Y., & Ikada, Y. (1988) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820221002 · Cited by 235
Ahmad, Z., Pandey, R., Sharma, S., & Khuller, G. K. (2006) · PubMed · Cited by 231
Interactions of Phospholipid Bilayer with Chitosan: Effect of Molecular Weight and pH
Fang, N., Chan, V., Mao, H.-Q., & Leong, K. W. (2001) · Biomacromolecules · doi:10.1021/bm015548s · Cited by 229
Rajesh Kumar, S., Ishaq Ahmed, V. P., Parameswaran, V., Sudhakaran, R., Sarath Babu, V., & Sahul Hameed, A. S. (2008) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2007.12.004 · Cited by 227
SADEGHI, A., DORKOOSH, F., AVADI, M., WEINHOLD, M., BAYAT, A., DELIE, F., GURNY, R., LARIJANI, B., RAFIEETEHRANI, M., & JUNGINGER, H. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.03.004 · Cited by 223
Douglas, K. L., & Tabrizian, M. (2005) · Journal of Biomaterials Science, Polymer Edition · doi:10.1163/1568562052843339 · Cited by 210
Evaluation of mucoadhesive properties of chitosan microspheres prepared by different methods
Dhawan, S., Singla, A. K., & Sinha, V. R. (2004) · AAPS PharmSciTech · doi:10.1208/pt050467 · Cited by 206
Nano-encapsulation of azole antifungals: Potential applications to improve oral drug delivery
Pandey, R., Ahmad, Z., Sharma, S., & Khuller, G. K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.05.027 · Cited by 192
TSAI, M., BAI, S., & CHEN, R. (2008) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2007.06.015 · Cited by 177
Formulation and characterization of amphotericin B–chitosan–dextran sulfate nanoparticles
TIYABOONCHAI, W., & LIMPEANCHOB, N. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.08.013 · Cited by 173
Immune stimulating activity of two new chitosan containing adjuvant formulations
Seferian, P. G., & Martinez, M. L. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00248-6 · Cited by 172
Sarmento, B., Martins, S., Ribeiro, A., Veiga, F., Neufeld, R., & Ferreira, D. (2006) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-005-9010-3 · Cited by 171
Chitosan-dextran Sulfate Nanoparticles for Delivery of an Anti-angiogenesis Peptide
Chen, Y., Mohanraj, V. J., & Parkin, J. E. (2003) · International Journal of Peptide Research and Therapeutics · doi:10.1007/bf02442596 · Cited by 166
Atomic force microscopy of gastric mucin and chitosan mucoadhesive systems
Deacon, M., McGurk, S. L., Roberts, C. J., Williams, P. M., Tendler, S. J. B., Davies, M. C., Davis, S. S., & Harding, S. E. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3480557 · Cited by 164
Galactosylated chitosan–graft–dextran as hepatocyte-targeting DNA carrier
Park, Y. K., Park, Y. H., Shin, B. A., Choi, E. S., Park, Y. R., Akaike, T., & Cho, C. S. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00298-4 · Cited by 163
Bozkir, A., & Saka, O. M. (2004) · Drug Delivery · doi:10.1080/10717540490280705 · Cited by 163
In vitro degradation of chitosan by bacterial enzymes from rat cecal and colonic contents
Zhang, H., & Neau, S. H. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00011-x · Cited by 160
Kotzé, A. F., Thanou, M. M., Lueben, H. L., De Boer, A. G., Verhoef, J. C., & Junginger, H. E. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980233c · Cited by 158
Efficacy and Mechanism of Action of Chitosan Nanocapsules for Oral Peptide Delivery
Prego, C., Fabre, M., Torres, D., & Alonso, M. J. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9570-8 · Cited by 155
Aspden, T., Illum, L., & Skaugrud, Ø. (1996) · European Journal of Pharmaceutical Sciences · doi:10.1016/0928-0987(95)00026-7 · Cited by 146
Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery
Bhattarai, N., Ramay, H. R., Chou, S.-H. S., & Zhang, M. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.2.181 · Cited by 141
Chitosan-Alginate Microparticles as a Protein Carrier
Coppi, G., Iannuccelli, V., Leo, E., Bernabei, M. T., & Cameroni, R. (2001) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100104314 · Cited by 135
Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor
Aktaş, Y., Andrieux, K., Alonso, M. J., Calvo, P., Gürsoy, R. N., Couvreur, P., & Çapan, Y. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.027 · Cited by 135
Evaluation of the Mucoadhesive Properties ofN-Trimethyl Chitosan Chloride
Snyman, D., Hamman, J. H., & Kotzé, A. F. (2003) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120016684 · Cited by 119
Polymer Based Drug Delivery Systems for Mycobacterial Infections
Pandey, R., & Khuller, G. K. (2004) · Current Drug Delivery · doi:10.2174/1567201043334669 · Cited by 116
Designing chitosan-dextran sulfate nanoparticles using charge ratios
Chen, Y., Mohanraj, V. J., Wang, F., & Benson, H. A. (2007) · AAPS PharmSciTech · doi:10.1208/pt0804098 · Cited by 111
Wang, Y. (2000) · Drug Delivery · doi:10.1080/107175400455173 · Cited by 110
Chitosan-Mediated and Spatially Selective Electrodeposition of Nanoscale Particles
Wu, L., Lee, K., Wang, X., English, D. S., Losert, W., & Payne, G. F. (2005) · Langmuir · doi:10.1021/la047420c · Cited by 101
Chavanpatil, M. D., Khdair, A., & Panyam, J. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9203-2 · Cited by 98
Charlton, S. T., Davis, S. S., & Illum, L. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.014 · Cited by 81
Intestinal Absorption of Octreotide Using Trimethyl Chitosan Chloride: Studies in Pigs
Thanou, M., Verhoef, J. C., Verheijden, J. H. M., et al. (2001) · Pharmaceutical Research · doi:10.1023/a:1011092613951 · Cited by 79
Mei, D. F., Mao, S., Sun, W., et al. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.06.031 · Cited by 79
Iskakov, R. M., Kikuchi, A., & Okano, T. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00551-x · Cited by 78
Effect of liposomalization on the antitumor activity, side-effects and tissue distribution of CPT-11
Sadzuka, Y., Hirotsu, S., & Hirota, S. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00031-7 · Cited by 74
Three-dimensional polymeric systems for cancer cell studies
Xu, F., & Burg, K. J. L. (2007) · Cytotechnology · doi:10.1007/s10616-007-9065-4 · Cited by 69
The limiting role of mucus in drug absorption: Drug permeation through mucus solution
Bhat, P. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04120-6 · Cited by 66
Preparation of alginate gel beads containing chitosan nicotinic acid salt and the functions
Murata, Y., Toniwa, S., Miyamoto, E., & Kawashima, S. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00026-0 · Cited by 49
Pharmacoscintigraphic Evaluation of Polysorbate80-Coated Chitosan Nanoparticles for Brain Targeting
Soni, S., Babbar, A. K., Sharma, R. K., et al. (2005) · American Journal of Drug Delivery · doi:10.2165/00137696-200503030-00004 · Cited by 20
Cited by
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Sapsford, K. E., Algar, W. R., Berti, L., Gemmill, K. B., Casey, B. J., Oh, E., Stewart, M. H., & Medintz, I. L. (2013) · Chemical Reviews · doi:10.1021/cr300143v · Cited by 1,423
An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery
Mohammed, M., Syeda, J., Wasan, K., & Wasan, E. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9040053 · Cited by 1,362
The transferrin receptor and the targeted delivery of therapeutic agents against cancer
Daniels, T. R., Bernabeu, E., Rodríguez, J. A., Patel, S., Kozman, M., Chiappetta, D. A., Holler, E., Ljubimova, J. Y., Helguera, G., & Penichet, M. L. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.07.016 · Cited by 807
Polymeric nanoparticles for drug delivery to the central nervous system
Patel, T., Zhou, J., Piepmeier, J. M., & Saltzman, W. M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.006 · Cited by 565
Metadata
- Authors
- Nagpal, K., Singh, S. K., & Mishra, D. N.
- Venue
- CHEMICAL & PHARMACEUTICAL BULLETIN
- Publisher
- Pharmaceutical Society of Japan
- Published
- 2010
- Volume
- 58
- Issue
- 11
- Pages
- 1423-1430
- ISSN
- 0009-2363 (ISSN-L)
- 1347-5223
- OpenAlex
- W2037306331
- Cited by
- 660
- References
- 92
- FWCI
- 18.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.